Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Hold

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Dec 23, 2021 8:33am

153 Views

Post# 34257332

RE:Hold

Shorts need to cover at one point. They went a bit far hoping for a lot of extra shares from recent financing but it is only 13 millions and not everyone is selling. Yesterday alone we had 3.5 million shares traded not to mention days before that. Now let's see how 7million shares shorted will be covered when we are at 50million mc for a phase 2 drug that worth more than 1 billion.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments